Ontario’s Russell Alexander Pens New Book Offering Advice to Couples Getting ‘Zoom Divorces’ Family lawyer anticipates rise in online divorce hearings with increase in Covid transmission
TORONTO, Ontario — Longtime Ontario family lawyer Russell Alexander’s latest book “Zoom Divorce” is now available on Amazon and gives sound advice to couples going through divorce in the pandemic era on virtual lawyer meetings and legal hearings by way of videoconferencing.
“Courts are pretty traditional places, so it took a global pandemic for judges to loosen the rules enough to try holding a divorce hearing over Zoom,” said Alexander. “But once we got the hang of it, they turned out to be less stressful and less expensive for our clients, and more accessible than a traditional court hearing in many respects, especially for working parents and those with young children.”
Alexander said that Zoom divorce hearings can allow couples to avoid taking the day off work or avoid having to find childcare just to trek to the courthouse for a routine hearing. They are also helpful for people who are leaving an abusive spouse since they can avoid seeing their abuser in person. And they give lawyers the option to work with clients who may live in remote areas and would otherwise struggle to find legal representation.
When the pandemic began to wane earlier this year, the Ontario Superior Court of Justice moved to cut back on videoconferencing beginning in April, requiring that in-person hearings be the default. Alexander opposed the move, starting an online petition that received over 1,500 signatures and leading an ad-hoc committee of seasoned lawyers throughout Ontario that seeks to preserve Zoom hearings.
But Alexander said that videoconferencing remains available in many areas, depending on the judge and jurisdiction, and throughout other courts in Canada. He also anticipates that it could make a comeback, especially if the return to school and more in-person court hearings lead to more coronavirus infections, continued high gas prices make travel more expensive and family lawyers continue to push back against requirements for in-person hearings.
He said his new book will help couples who are going through a “Zoom divorce” with real-life examples and tips to ensure the best results.
“Just because a divorce hearing isn’t being held in a traditional courtroom, that doesn’t mean you don’t have to prepare for it,” he added. “From getting familiar with the software to knowing how to come off best in a videoconference testimony, there are lots of tips that can help you work towards the best results.”
Doctors Offer Vaccine Insights as New Boosters are Readied
Santa Ana, CA, September 26, 2022 — Another COVID booster is on the horizon — this one targeting the BA.4 and BA.5 variants — opening the door for more discussion surrounding vaccine efficacy and the overall pandemic response.
Pointing to animal studies that date back more than 20 years, Dr. George Fareed of the Imperial Valley in California recently shared his perspective on why the type of vaccines being used have fallen short of expectations and possibly prolonged the pandemic.
“If you immunize a population in the pandemic with a vaccine that suppresses, to some extent, replication or gives some mild benefit of some sort in terms of the severity of the illness, it’s not a safe thing to do,” Dr. Fareed said. “You always use a blocking or a sterilizing vaccine — one that doesn’t allow the virus to break through. And that’s absolutely what we did not accomplish with these gene therapy-type vaccines … it doesn’t provide immunity or even prevent the infection for more than a few weeks or months … so it allows for a mutable virus to generate variants and perpetuate a pandemic.”
In the early days of COVID-19, Dr. Fareed and Dr. Brian Tyson created an early treatment protocol comprised of both pharmaceuticals and nutraceuticals. To date, they have successfully treated 12,000 COVID patients (and counting).
In their book, Overcoming the COVID Darkness, Drs. Fareed and Tyson chronicle their journey, detailing (in layperson’s terms) their COVID treatment formula and attempting to provide readers with clarity about the illness — with an entire chapter devoted to the vaccine response. The book also contains testimonials from patients and other doctors, research studies, news clippings, a letter they wrote to congress and a national COVID plan that can be adapted for future pandemics.
“Instead of the vaccine, people should have been treated early in the illness, and then they would have developed strong immunity, and we wouldn’t have all these new variants,” Dr. Fareed added.
About the Authors
Dr. George Fareed graduated from Harvard Medical School with Honors and completed a medical internship at Peter Bent Brigham Hospital. He has worked at NIAID, at Harvard Medical School and at UCLA School of Medicine.
He was a founder and director of scientific planning of a biotech company, Ingene (International Genetic Engineering, Inc.). Since 1991, Dr. Fareed has worked clinically in primary medical care in the Imperial Valley of California. He has been on the frontline for early COVID-19 treatment, and has practiced the whole spectrum of COVID-19 care, treating outpatients as well as inpatients as a hospitalist. He testified on November 19, 2020, in the Senate Hearing on early COVID-19 treatment.
Dr. Brian Tyson is a board-certified family practitioner who worked as an emergency physician at Arrowhead Regional Medical center for 13 years and as a hospitalist physician for 14 years before opening his own urgent care in 2018.
Dr. Tyson was the Program Medical Director for Cogent Healthcare and Beaver Medical Group. His experience with COVID-19 has been exceptional, with over 30,000 patients evaluated, and zero deaths with early treatment.
His urgent care serves a high-risk population that includes two nursing homes, and his success was due to his aggressive early management. Due to his proven methodology, Dr. Tyson is considered a frontline COVID-19 treatment expert and has been featured on multiple media sites.
::::25,000 TICKETS ALREADY SOLD!:::: A HIGHLY ANTICIPATED & MESMERIZING ONTARIO PREMIERE FOR ILLUMI – A DAZZLING WORLD OF LIGHTS BY CAVALIAThe largest light, sound and multimedia show in the world put stars and lights in visitors of all ages’ eyesPHOTOS OF THE DAZZLING EVENING: https://we.tl/t-4B05gXiZ5Y PHOTO OF CREATOR NORMAND LATOURELLE: https://we.tl/t-cyKvefE7NZ RED CARPET PHOTOS: https://we.tl/t-MBxogF7cu8 MISSISSAUGA, ONTARIO (FRIDAY, SEPTEMBER 23, 2022) #illumiMississauga – After months of anticipation, thousands of guests and locals flocked to illumi on Tuesday night to celebrate the opening of their new location in Mississauga, Ontario. Underneath the impressive illumi Tree of Lights, Normand Latourelle, creator of illumi, kicked off the festivities and glowed with pride as he reflected on the hard and dedicated work it took to bring the joy of illumi to GTA residents and beyond.
ALREADY A ROARING SUCCESS Latourelle’s passion and vision coupled with the dedication of his team has more than paid off. The latest GTA attraction is sparking tons of buzz and has already sold 25,000 tickets for its first edition in Mississauga! Of the six nights that illumi has run so far, four have been completely sold out.
With ticket prices comparable to those of a movie ticket and free parking close to the entrance, illumi is a perfect choice for a fun outing with your friends, family, or special someone.
AN EVENING WITH LIGHTS, MAGIC AND AMAZEMENT What’s historically been a quiet area of Mississauga at night could not have been more lively on Tuesday evening for the official Ontario premiere of illumi – A Dazzling World of Lights. Over 3,500 visitors of all ages came to take in the sights at illumi. No matter where visitors turned their heads, they could catch families, couples and friends snapping pictures with their loved ones, interacting with light structures like never before, and looking around with sheer wonder and amazement.
On top of exploring the 14 universes at illumi, visitors got the chance to stop for a warm delicious bite at our food trucks or at the illumi food and beverage tent and round out the evening with a visit to the gift shop for souvenirs.
SOME FAMILIAR FACES DAZZLED BY THE LIGHTS Several notables joined illumi for the festivities on Tuesday night and struck a pose on the red carpet. Among them was Mississauga Councillor Carolyn Parrish, CFL legend Michael Pinball Clemons, actors Katie Douglas, Tyssen Smith, TJ McGibbon, Dani Kind, and Jenna Warren as well as other public figures Sarain Fox, Melissa Grelo, Grego Minot, Mike Drolet, Radheyan Simonpillai, Ella Clarens, Leah Collins, Christina Cravero, Azalea Hart, Stacy Lee Kong, Jay Kana, and Kaysey Davis.ILLUMI – THE LARGEST LIGHT, SOUND AND MULTIMEDIA SHOW IN THE WORLD Kids and adults embark on a spectacular outdoor journey on foot through 14 magical worlds across a 600,000-sq-ft site (equivalent to ten football fields!) located near the intersection of the 407 and Hurontario Street. Brought to life by cutting-edge programming technologies, the immersive illumi universe features high-definition projections, jaw-dropping, state-of-the-art animatronic creatures, thousands of light structures, and over 20 million brilliant LED bulbs.
A SPOOKY SURPRISE COMING THIS HALLOWEEN Starting mid-October, illumi will introduce its first seasonal universe, a glowing pumpkin patch filled with 3,000 fiery-eyed pumpkins. Those who walk through this glowing field will see the first illumi installation where the lights look back at you, literally!
Visitors will also have the chance to enjoy special Halloween touches in the following universes: The Crazy Boulevard, Europea Place, The illumi Tree of Lights and its Village, and The Happiest Farm. Expect marvelous monsters, gleaming ghosts, wicked witches, and thousands of jack-o-lanterns of all shapes and sizes.ILLUMI – A DAZZLING WORLD OF LIGHTS BY CAVALIA AT A GLANCEAn epic multimedia journey around the worldA magical and extraordinary nocturnal outdoor journey20 million+ LED lightsThousands of structures spread throughout 14 magical universes, including one rotating seasonal universeA 600,000 square feet site, the equivalent of 10 football fields!Experience a magical walk under the stars like never before!SPOOKY AT ILLUMI, FROM OCTOBER 23THE HOLIDAY AT ILLUMI, FROM NOVEMBER 23 ABOUT CAVALIA AND ILLUMI Cavalia is a Canadian entertainment company that specializes in creating, producing and marketing large-scale live shows and events. A family business founded by Normand Latourelle, the company’s mission is to create the unexpected. Its expertise in high technology, multimedia and special effects creates magical, unique, never-before-seen experiences. illumi – A Dazzling World of Lights is Cavalia’s latest creation: a magical and captivating nocturnal journey created with thousands of monumental light sculptures. With illumi, Cavalia has established a multigeneration tradition in Quebec over the last 3 years, welcoming over 1.5 million visitors of all ages to date.
Follow illumi – A Dazzling World of Lights on social media!
Instagram: @illumiMississauga Facebook: @illumiMississauga TikTok: @illumiinsauga #illumiMississaugaEDITORIAL CALENDARWHAT: illumi – A Dazzling World of Lights by Cavalia WHEN: Now through January 8, 2023 WHERE: 7174 Derrycrest Dr, Mississauga, ON, L5W 1N4 FREE PARKING TICKETS & INFO: mississauga.illumi.com
Faith and First Responders: How Believing in a Higher Power Can Promote Healing
Antioch, CA, September 23, 2022 — If he were given a chance to travel back in time, make different choices and avoid a prison sentence, Norm Wielsch says he would decline the offer. In 2013, the former undercover narcotic agent was sentenced to 14 years in federal prison after he pled guilty to corruption charges, and it was there, behind prison walls, where he finally found healing through faith.
“If you don’t believe in a higher power, there’s no rhyme or reason to life,” Wielsch said in a recent interview. “Life is just a series of incidents that happen. But if you truly believe that there is a higher power, and there’s a reason for things that happen, I believe that you can adjust to it, and cope with it a little bit better.”
As a police officer for 25 years, Wielsch witnessed his share of trauma and would later fall into a downward spiral following his own diagnosis of PTSD. He served 8 years of his 14-year sentence and emerged from federal prison determined to help others — particularly first responders — heal from trauma.
Wielsch’s new book, Christ Centered Healing of Trauma: Healing a Broken Heart (and companion small group study guide), teaches foundational principles and tools for resolving issues related to traumatic life events.
Readers will learn how trauma affects the heart, body and soul; how to manage emotions; how to identify the root cause of emotional pain; and how to begin the healing process.
Through a bible study portion, readers will learn God's plan for salvation and healing. Included are numerous sample prayers to guide readers through the healing process.
Wielsch’s Christ-Centered healing method was originally designed to minister to first responders and combat veterans but is also appropriate for counselors, pastors, chaplains and anyone whose lives are impacted by trauma.
“This book is not only for the victims of trauma, but for their husbands, wives, daughters, sons and parents who suffer right along with them,” Wielsch said. “They are wounded people as well. Hurt people, hurt people. Since our families are the closest to us, we tend to hurt them more than we intend.”
About the Author
Norm Wielsch was a law enforcement officer for over 25 years — 16 of those as an undercover narcotic agent. In 1998, he was diagnosed with an incurable neuro-muscular disease, and after more than 30 surgeries, he became addicted to opioids. Wielsch was diagnosed with PTSD, and then his daughter was diagnosed with a serious illness and given a poor prognosis. In a downward spiral, Wielsch made a series of bad decisions that landed him in federal prison.
While incarcerated, he obtained a master’s degree in Theology and Counseling, a Doctorate in Christian Counseling, and a Drug and Alcohol Counseling Degree. He currently works at a men's residential treatment facility as a registered alcohol and drug counselor and pastoral care provider. He is a working credentialed chaplain who hopes to one day launch a first responder ministry.
Wielsch also has a master’s degree in Law Enforcement Management and is an expert in law enforcement tactics, criminal investigations, pursuit driving, high risk search warrant service, PTSD and the police culture.
Faith and First Responders: How Believing in a Higher Power Can Promote Healing
Antioch, CA, September 23, 2022 — If he were given a chance to travel back in time, make different choices and avoid a prison sentence, Norm Wielsch says he would decline the offer. In 2013, the former undercover narcotic agent was sentenced to 14 years in federal prison after he pled guilty to corruption charges, and it was there, behind prison walls, where he finally found healing through faith.
“If you don’t believe in a higher power, there’s no rhyme or reason to life,” Wielsch said in a recent interview. “Life is just a series of incidents that happen. But if you truly believe that there is a higher power, and there’s a reason for things that happen, I believe that you can adjust to it, and cope with it a little bit better.”
As a police officer for 25 years, Wielsch witnessed his share of trauma and would later fall into a downward spiral following his own diagnosis of PTSD. He served 8 years of his 14-year sentence and emerged from federal prison determined to help others — particularly first responders — heal from trauma.
Wielsch’s new book, Christ Centered Healing of Trauma: Healing a Broken Heart (and companion small group study guide), teaches foundational principles and tools for resolving issues related to traumatic life events.
Readers will learn how trauma affects the heart, body and soul; how to manage emotions; how to identify the root cause of emotional pain; and how to begin the healing process.
Through a bible study portion, readers will learn God's plan for salvation and healing. Included are numerous sample prayers to guide readers through the healing process.
Wielsch’s Christ-Centered healing method was originally designed to minister to first responders and combat veterans but is also appropriate for counselors, pastors, chaplains and anyone whose lives are impacted by trauma.
“This book is not only for the victims of trauma, but for their husbands, wives, daughters, sons and parents who suffer right along with them,” Wielsch said. “They are wounded people as well. Hurt people, hurt people. Since our families are the closest to us, we tend to hurt them more than we intend.”
About the Author
Norm Wielsch was a law enforcement officer for over 25 years — 16 of those as an undercover narcotic agent. In 1998, he was diagnosed with an incurable neuro-muscular disease, and after more than 30 surgeries, he became addicted to opioids. Wielsch was diagnosed with PTSD, and then his daughter was diagnosed with a serious illness and given a poor prognosis. In a downward spiral, Wielsch made a series of bad decisions that landed him in federal prison.
While incarcerated, he obtained a master’s degree in Theology and Counseling, a Doctorate in Christian Counseling, and a Drug and Alcohol Counseling Degree. He currently works at a men's residential treatment facility as a registered alcohol and drug counselor and pastoral care provider. He is a working credentialed chaplain who hopes to one day launch a first responder ministry.
Wielsch also has a master’s degree in Law Enforcement Management and is an expert in law enforcement tactics, criminal investigations, pursuit driving, high risk search warrant service, PTSD and the police culture.
Celebrating 10 Years of Pharmacist Enabled Clinical Care in Alberta
EDMONTON, AB, Sept. 23, 2022 /CNW/ - On September 25, 2022, we celebrate World Pharmacists Day and this year's theme of "Pharmacy United in Action for a Healthier World." Alberta has been and continues to be a leader in the profession of pharmacist practice, with a practice model that offers pharmacists as an additional access point for patients seeking primary care in their local community. Services like Comprehensive Annual Care Planning, Prescribing of Medications, and Administering Drugs and Vaccines by Injection are all part of the unique model that has helped to improve patient health outcomes in Alberta over this past decade. The Alberta Pharmacists' Association (RxA) acknowledges Alberta Health for working with our association towards establishing the model back in 2012, supporting pharmacist-led care as an integral part of the healthcare budget. The "Alberta Model" for pharmacist practice, as it has come to be known around the world, supports Albertans to be able to access the care they need from their community pharmacist.
Most recently, when the COVID-19 pandemic began in 2020, many primary care providers closed their doors to the public, but not Alberta's community pharmacists. Instead, as a result of the Alberta Model, pharmacists were able to do what they do best in Alberta, which is remaining open and accessible to the public, adapting to public health measures, and using their advanced scope of practice to renew patients' prescriptions, administer medications by injection, provide laboratory requisitions to patients in need, and offering information and resources about how to stay safe during the pandemic. Without this model for pharmacist led services established 10 years ago, much of this might not have been possible, and the strain on the healthcare system could have been so much greater as a result.
This Sunday, September 25, join us in celebration of your community pharmacist and pharmacists around the world. People in all walks of life all over the world deserve access to quality care, and we are proud that our Alberta Model has supported pharmacists' providing patient focused care these past ten years. The next time you need more of your medication, ask your pharmacist to prescribe it for you. Need to update your vaccination status for your upcoming holiday? Your pharmacist will be happy to help. No matter where you are in the province, your local community pharmacist is ready and available to meet your care needs.
The pharmacist will see you now.
For over two decades, the Alberta Pharmacists' Association (RxA) has been a champion for pharmacists in Alberta. We play an integral role in expanding pharmacists' practice, and we continue to advocate on their behalf towards excellence in patient care.
Health Canada approves Takeda's LIVTENCITY™ (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection
TORONTO, Sept. 20, 2022 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that Health Canada has authorized (Notice of Compliance) LIVTENCITY™ (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) infection/disease who are refractory (with or without genotypic resistance) to one or more prior antiviral therapies.1 Compared to conventionally used antivirals to treat post-transplant CMV, LIVTENCITY offers twice the efficacy1 and more than 10 times less toxicity.1*
LIVTENCITY was evaluated using the Health Canada priority review process which recognizes the significant unmet need for this patient population. The Canadian approval of LIVTENCITY represents the second market globally to receive authorization for this important CMV treatment.
"Health Canada's authorization of LIVTENCITY represents a much-needed treatment option for post-transplant patients with refractory/resistant CMV infection or disease," said Dr. Shariq Haider, Professor of Medicine McMaster University Division of Infectious Disease and General Medicine and Research Lead Transplant Malignant ID Juravinski Hospital and Cancer Center, Hamilton ON. "Until now, physicians have relied upon conventional non-indicated antiviral therapies as the only option to treat post-transplant CMV which can be difficult to manage post-transplant. The addition of an effective oral treatment for CMV, with a better safety profile, is welcome news for Canadian patients, physicians and the transplant community."
The approval of LIVTENCITY is based on the SOLSTICE Study which assessed the efficacy and safety of LIVTENCITY treatment compared to Investigator Assigned Treatment (IAT) in 350 Hematopoietic Stem Cell Transplant (HSCT) and Solid Organ Transplant (SOT) recipients with CMV infections that were refractory to treatment with ganciclovir, valganciclovir, foscarnet, or cidofovir, including CMV infections with or without confirmed resistance to 1 or more anti-CMV agents.1 Beneficial treatment effect was consistent regardless of transplant type, baseline CMV DNA viral load, genotypic resistance, CMV syndrome at baseline and age.1
"A diagnosis of CMV infection can be particularly unsettling for patients given the complex challenges associated with receiving a life-saving transplant," said Rute Fernandes, General Manager, Takeda, Canada. "Providing patients with the first indicated post-transplant CMV treatment underscores Takeda's commitment to finding solutions for patients where there is an unmet need, and we look forward to working with the appropriate agencies to bring LIVTENCITY to Canadians."
Current antiviral treatment options for post-transplant cytomegalovirus (CMV) infections have unfavorable toxicities, such as neutropenia or nephrotoxicity, that may impact patient care and transplant outcomes.2
About LIVITENCITY
LIVTENCITY, is a selective orally bioavailable benzimidazole riboside antiviral drug with a novel mechanism of action against human CMV (HCMV). LIVTENCITY attaches to the UL97 encoded kinase at the adenosine triphosphate (ATP) binding site, abolishing phosphotransferase needed in processes such as DNA replication, encapsidation, and nuclear egress of viral capsids.1
The recommended dose of LIVTENCITY is 400 mg (two 200 mg tablets) twice daily resulting in a daily dose of 800 mg.1 LIVTENCITY is intended for oral use only and can be taken with or without food.1
The primary efficacy endpoint was confirmed CMV viremia clearance (plasma CMV DNA concentration below the lower limit of quantification (<LLOQ; i.e., <137 IU/mL)) at Week 8. The key secondary endpoint was CMV viremia clearance and CMV infection symptom control at the end of Study Week 8 with maintaining this treatment effect through Study Week 16.1
For the primary endpoint, LIVTENCITY was superior to IAT (56% vs. 24%, respectively, p<0.001). For the key secondary endpoint, 19% vs. 10% achieved both CMV viremia clearance and CMV infection symptom control in the LIVTENCITY and IAT group, respectively (p=0.013).1
Most common adverse reactions with LIVTENCITY were: taste disturbance (44.8%), nausea (8.5%), vomiting (7.7%), immunosuppressant drug concentration level increased (6.4%), diarrhea (3.8%), abdominal pain (2.1%), neutropenia (1.7%), acute kidney injury (1.7%), anemia (1.3%), and decreased appetite (1.3%).1
Serious adverse events (SAEs) occurred less frequently in the LIVTENCITY group than in the IAT group (5.1% and 14.7%, respectively).1
No patients in the LIVTENCITY group experienced serious, drug-related neutropenia or febrile neutropenia.1
About CMV
CMV is a beta herpesvirus that commonly infects humans; serologic evidence of prior infection can be found in 40%-100% of various adult populations.3 CMV typically resides latent and asymptomatic in the body but may reactivate during periods of immunosuppression. Serious disease may occur in individuals with compromised immune systems, which includes patients who receive immunosuppressants associated with various types of transplants including hematopoietic stem cell transplant (HSCT) or solid organ transplant (SOT).4,5 Out of the estimated 200,000 adult transplants per year globally, CMV is one of the most common viral infections experienced by transplant recipients, with an estimated incidence rate between 16-56% in SOT recipients and 30-70% in HSCT recipients.6,7,8,9
In transplant recipients, reactivation of CMV can lead to serious consequences including loss of the transplanted organ and, in extreme cases, can be fatal.10,11 Existing therapies to treat post-transplant CMV infections may demonstrate serious side effects that require dose adjustments or may fail to adequately suppress viral replication.12,13,14,15,16 Additionally, existing therapies may require or prolong hospitalization due to intravenous administration, side effect management and monitoring for adequate hydration.10
About Takeda Canada Inc.
Takeda Canada Inc. is the Canadian organization of Takeda Pharmaceutical Company Limited (TSE: 4502) (NYSE: TAK), a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discovering and delivering life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit: takeda.com/en-ca
References
_________________________________________
1
LIVTENCITY™ Product Monograph. September 15, 2022
2
Maffini E, et al. Expert Rev Hematol. 2016;9:585-96; Stevens DR, et al. Transpl Infect Dis. 2015;17:163–73
3
de la Hoz R. Diagnosis and treatment approaches to CMV infections in adult patients. J Clin Virol. 2002;25:S1-S12.
4
Azevedo L, Pierrotti L, Abdala E, et al. Cytomegalovirus infection in transplant recipients. Clinics. 2015;70(7):515-523. doi:10.6061/clinics/2015(07)09.
5
Razonable RR, Eid AJ. A Viral infections in transplant recipients. Minerva Med. 2009;100(6):23.
6
Shannon-Lowe & Emery. The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein. Herpesviridae 2010, 1:4.
7
Styczynski J. Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation. Infect Ther. 2018;7:1-16.
8
Azevedo L, Pierrotti L, Abdala E, et al. Cytomegalovirus infection in transplant recipients. Clinics. 2015;70(7):515-523. doi:10.6061/clinics/2015(07)09.
de la Hoz R. Diagnosis and treatment approaches to CMV infections in adult patients. J Clin Virol. 2002;25:S1-S12.
11
Kenyon M, Babic A, eds. The European Blood and Marrow Transplantation Textbook for Nurses. Springer International Publishing; 2018. doi:10.1007/978-3-319-50026-3.
12
El Chaer et al. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood, 2016
13
Chemaly RF, Chou S, Einsele H, et al. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019;68(8):1420-1426. doi:10.1093/cid/ciy696.
14
Razonable RR, Eid AJ. A Viral infections in transplant recipients. Minerva Med. 2009;100(6):23.
15
Ljungman et al. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL7).Lancet Vol.19, Aug 2019.
16
Razonable & Humar. Cytomegalovirus in solid organ transplant recipients— Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation, Feb 2019.
*
Refers to acute kidney injury related to foscarnet and neutropenia related to valganciclovir/ganciclovir
SOURCE Takeda Canada Inc.
QEII Foundation to announce transformational gift for cancer care innovation
HALIFAX, NS, Sept. 20, 2022 /CNW/ - On Thursday, September 22, the QEII Foundation will announce its largest donation ever received to-date – a multimillion-dollar transformational gift that will impact cancer care in Atlantic Canada for generations to come.
One local family's incredible generosity will have a lasting effect on the way that cancer care is delivered at the QEII Health Sciences Centre, from supporting the development of groundbreaking cancer-fighting technologies, to fast-tracking upcoming innovation and discovery opportunities.
The family, with deep healthcare roots, are inspired to honour their late parents' legacy and have their multimillion-dollar gift help improve top-of-mind areas in cancer care – like improving patient outcomes, reducing wait times, attracting and retaining top medical professionals, and delivering the best patient care experience possible.
Together, with the QEII Foundation, the family is thrilled to help transform cancer care for Atlantic Canadians – through integrated, advanced, and compassionate care at the QEII Health Sciences Centre.
Announcement Details
WHAT
Members of the media are invited to attend a formal, milestone announcement revealing the identity of the donor family and their transformational gift in support of cancer care at the QEII Health Sciences Centre.
WHEN
Thursday, September 22, 2022 11 a.m. to noon.
WHERE
The Discovery Centre 1215 Lower Water St, Halifax, NS B3J 3S8
*Call Tanya MacLean (902 489 5664) upon arrival to set-up and for on-site interviews with donor family, QEII Foundation representatives and cancer care leadership.
SOURCE QEII FOUNDATION
Musk’s SpaceX could ignite private securities revolution
Petition for $10million private investment in Elon
Musk’s SpaceX could ignite private securities revolution
One of the world’s pioneering private companies, Elon Musk’s SpaceX, has been petitioned to accept nearly $10 million in private investors, as more individuals join the US crowdfunding revolution.
If SpaceX (Space Exploration Technologies Corp) did agree to a public equity crowdfunding raise or opened its shares to a secondary market for private securities, it would be a significant milestone for equity crowdfunding since it was enabled by the JOBS Act of 2012.
Caption: Petition for $10million private investment in Elon Musk’s SpaceX could ignite private securities revolution
And if companies like SpaceX opened their doors to public investment, there is greater potential for securities sold to retail as well as accredited investors to be traded on secondary market Alternative Trading Systems (ATSs).
A handful of these ATSs were recently granted operational permission by financial regulators to trade private securities and digital assets.
Equity crowdfunding is rocketing, raising $113.52 billion last year according to Pitchbook data, a year-on-year increase of 1,021%, while Forbes reported that the private securities market hit a record $7 trillion last year and is set to soar to $30 trillion by 2030.
The enormous potential is highlighted by the fact that the USA has 27 million private companies, yet only 1% are currently traded on an ATS.
Chris Lustrino, Founder and CEO of crowdfunding investor site Kingscrowd wrote to his 475,000 subscribers this week and highlighted the petition to Elon Musk’s space company:
“Perhaps one of the most exciting start-ups in existence right now is SpaceX. I know that I would love the opportunity to invest in SpaceX - but that opportunity has never happened.
“That's why the folks at Spaced Ventures (a public investment platform for the space industry) have opened a petition asking SpaceX to raise capital online. The petition went live on Wednesday. And investors have already indicated more than $8 million (now $10 million) in potential interest for it.
“There's no guarantee that SpaceX will respond. But with that strong a response (via the petition), I think that if SpaceX ever did raise capital online, the raise would sell out in a matter of hours.”
Spaced Ventures’ website says of the organization: “We are passionate about entrepreneurship, finance, and all things space, and are deeply committed to the Spaced Ventures mission of making the industry accessible to companies and investors of all sizes.”
The commercial growth potential from the Spaced Ventures petition opening a door is not lost on Rialto Markets, an equity crowdfunding broker-dealer and operator of a secondary market ATS for private securities, whose award-winning visionary CEO and Co-Founder Shari Noonan told me:
“If exciting privately held tech companies in frontier markets, such as SpaceX, were to accept retail and accredited investors in their growth stages this would signal a massive and symbolic change in investment for private securities.
“Where previously accredited or institutional investors had greater access to private companies, we could now see everyday people finding their way into that investment space and simultaneously expanding their investment portfolio and growth opportunities. while potentially delivering greater liquidity for this market.”
Soldiers’ Blood and Bloodied Money Delivers Hard-Hitting History Lesson
Dallas, TX, September 20, 2022 — Allen B. Clark returned from the Vietnam War a double-leg amputee. It took 15 months of rehabilitation, 20 surgeries, eight years of psychotherapy and his faith in God to help him heal.
Through the years, Clark became involved in politics and was eventually appointed as an assistant secretary at the National Department of Veterans Affairs. It was through that appointment where Clark met and mentored hundreds of veterans and listened to their stories. The blood lost — the lives lost — haunted him, and he began to study the history of wars intensely. The undertaking consumed him, and he didn’t stop until he uncovered what he calls “the story behind the story” of why the United States gets involved in wars.
“In Latin, it’s cui bono? — who profits?” Clark said.
In his revealing new book, Soldiers’ Blood and Bloodied Money: Wars and the Ruling Elites, Clark shares the results of his extensive and concentrated research. His findings, drawn from sources published as far back as 150 years ago, point to individuals and institutions throughout history who have fostered and fomented horrendous wars, including arms merchants; religious entities and their leaders; politicians; international bankers; media titans; and lawyers.
With a special focus on the American Revolution, Civil War, Spanish-American War and the “Banana, Banker and Oil” wars in the Americas, Soldiers’ Blood and Bloodied Money aims to reveal the political, financial, business, religious, social and propaganda truths behind the initiation of wars.
“These truths illustrate that we young patriots, who have gone off to fight in wars, are merely pawns in a much larger chess game of life — a game where the captains and kings and knights and bishops are the ones who often profit immeasurably in terms of financial gain or increases in power,” Clark wrote in his book. “Meanwhile, we perish or suffer immense physical and emotional wounds from which many of us never heal.”
About the Author
The Honorable Allen B. Clark is a 1963 West Point graduate and PTSD survivor who lost both legs below the knees in 1967 following an enemy mortar barrage while serving in Vietnam. He is a recipient of a Silver Star, America’s third-highest decoration for Gallantry in Action, a Purple Heart, and the Combat Infantryman’s Badge.
He has served as a special assistant to the governor of Texas and as the Assistant Secretary for Veterans Liaison and Program Coordination, and Director of the National Cemetery System in the U.S. Department of Veterans Affairs. In 1993, he was recognized by the Military Chaplains Association with its National Citizenship Award. He is a frequent motivational speaker. In early 2018, Allen received the Patriot Award from the Greater Dallas Military Foundation, and later that year, he received the Sons of the Flag Legacy Award.
For more insights into his book, visit the reviews at
ILLUMI – THE LARGEST LIGHT, SOUND AND MULTIMEDIA SHOW IN THE WORLD
